Community Guide Branch, National Center for Health Marketing, CDC, Atlanta, Georgia 30333, USA.
Am J Prev Med. 2010 Jan;38(1):110-7. doi: 10.1016/j.amepre.2009.09.031.
Most major medical organizations recommend routine screening for breast, cervical, and colorectal cancers. Screening can lead to early detection of these cancers, resulting in reduced mortality. Yet, not all people who should be screened are screened regularly or, in some cases, ever. This report presents results of systematic reviews of effectiveness, applicability, economic efficiency, barriers to implementation, and other harms or benefits of provider reminder/recall interventions to increase screening for breast, cervical, and colorectal cancers. These interventions involve using systems to inform healthcare providers when individual clients are due (reminder) or overdue (recall) for specific cancer screening tests. Evidence in this review of studies published from 1986 through 2004 indicates that reminder/recall systems can effectively increase screening with mammography, Pap, fecal occult blood tests, and flexible sigmoidoscopy. Additional research is needed to determine if provider reminder/recall systems are effective in increasing colorectal cancer screening by colonoscopy. Specific areas for further research are also suggested.
大多数主要医学组织建议对乳腺癌、宫颈癌和结直肠癌进行常规筛查。筛查可以早期发现这些癌症，从而降低死亡率。然而，并非所有应接受筛查的人都定期接受筛查，或者在某些情况下从未接受过筛查。本报告介绍了对提供者提醒/召回干预措施以增加乳腺癌、宫颈癌和结直肠癌筛查的有效性、适用性、经济效率、实施障碍以及其他危害或益处进行系统评价的结果。这些干预措施涉及使用系统在个人客户应进行（提醒）或过期（召回）特定癌症筛查测试时通知医疗保健提供者。对 1986 年至 2004 年发表的研究进行的这项审查中的证据表明，提醒/召回系统可以有效地增加乳房 X 光检查、巴氏涂片、粪便潜血试验和乙状结肠镜检查的筛查。需要进一步研究以确定提供者提醒/召回系统是否可以通过结肠镜检查有效增加结直肠癌的筛查。还建议了进一步研究的具体领域。
